Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 14Glioblastoma 10Pancreatic Neoplasms 9Breast Neoplasms 9Neoplasms 8Glioma 8Prostatic Neoplasms 5Colonic Neoplasms 5Triple Negative Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Ovarian Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Carcinoma 4Astrocytoma 4Oligodendroglioma 3Fallopian Tube Neoplasms 3Colorectal Neoplasms 3Central Nervous System Neoplasms 3Carcinoma, Merkel Cell 3Carcinoma, Hepatocellular 3Brain Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma 2Osteosarcoma 2Neoplasms, Plasma Cell 2Neoplasm Metastasis 2Myelodysplastic Syndromes 2Lymphoma, T-Cell, Cutaneous 2

Interventions

pembrolizumab 7Paclitaxel 4Cisplatin 3Carboplatin 3camrelizumab 2Radiotherapy 2Radiosurgery 2Nivolumab 2Immunotherapy 2Immune Checkpoint Inhibitors 2tremelimumab 1toripalimab 1spartalizumab 1sinoporphyrin sodium 1poly ICLC 1penpulimab 1durvalumab 1avelumab 1Tramadol 1Tadalafil 1Surgical Procedures, Operative 1S 1 (combination) 1Radiation 1Poly(ADP-ribose) Polymerase Inhibitors 1Photochemotherapy 1Pemetrexed 1Oxaliplatin 1Morphine 1Leucovorin 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Parkinson Disease 4, Autosomal Dominant Lewy Body × poly ICLC × Clear all
NCT02834052 2024-06-07

Pembrolizumab + Poly-ICLC in MRP Colon Cancer

Augusta University

Phase 1/2 Completed
42 enrolled 13 charts
Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡